中国组织工程研究 ›› 2011, Vol. 15 ›› Issue (39): 7399-7402.doi: 10.3969/j.issn.1673-8225.2011.39.045

• 骨与关节临床实践 clinical practice of the bone and joint • 上一篇    下一篇

腰椎间盘突出症实施临床路径治疗的医疗费用控制及效果评价

卢  燊,陈秋燕,范召辉,奚江明   

  1. 深圳市宝安区石岩人民医院,广东省深圳市518108
  • 收稿日期:2011-06-01 修回日期:2011-08-18 出版日期:2011-09-24
  • 作者简介:卢燊★,男,1972年生,广东省高州市人,汉族,中山大学公共卫生学院在读硕士,副主任医师,主要从事创伤骨科研究。 248686138@qq.com

Clinical pathway to treat lumbar disc herniation: Cost control and effective evaluation

Lu Shen, Chen Qiu-yan, Fan Zhao-hui, Xi Jiang-ming   

  1. Shiyan People’s Hospital of Shenzhen City, Shenzhen  518108, Guangdong Province, China
  • Received:2011-06-01 Revised:2011-08-18 Online:2011-09-24
  • About author:Lu Shen★, Studying for master’s degree, Associate chief physician, Shiyan People’s Hospital of Shenzhen City, Shenzhen 518108, Guangdong Province, China 248686138@qq.com

摘要:

背景:临床路径是美国和欧洲医院应用在临床医疗服务中用来控制医疗费用的一种手段。
目的:探讨实施临床路径的医疗费用控制效果。
方法:以卫生部制定的腰椎间盘突出症手术医疗临床路径为基础,结合医院自身实际情况设计相应临床路径,对同类手术的临床路径和非临床路径患者医疗费用进行对照研究,通过医院医疗费用信息系统提取相关数据并建立数据库,并对各组数据进行相关统计学分析。
结果与结论:与非临床路径患者比较,进入临床路径患者总住院天数、手术前后住院天数、总住院费用、手术前后及手术日住院费均显著减少(P < 0.05)。说明临床路径可缩短患者住院时间,降低住院费用,规范诊疗行为,节约卫生资源。

关键词: 医疗费用, 腰椎间盘突出症, 临床路径, 诊疗行为, 住院时间 

Abstract:

BACKGROUND: Clinical pathway is widely used in U.S. and European hospitals as a successful method to control medical costs.
OBJECTIVE: To analyze the effects of controlling medical costs after implementation of clinical pathway.
METHODS: The corresponding clinical pathway was designed based on the clinical pathway of Ministry of Health and hospital practice, and a comparison study was peformed in the medical costs of the clinical pathway group and the control group in the way of setting up database through the hospital information system and statistically analyzing the related data.
RESULTS AND CONCLUSION: Compared to the control group, the total length of the hospital stay, the length of the hospital stay before and after surgery, the total medical costs, the surgery medical costs and medical care costs before and after surgery in hospital were declined in patients who took clinical pathways (P < 0.05). It means that the clinical pathway practice can decline the length of hospital stay, reduce medical costs, standardize the diagnosis and treatment behavior and conserve the health resources.

中图分类号: